Publicaciones en colaboración con investigadores/as de University of Southampton (18)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

2023

  1. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)

    Leukemia

2019

  1. Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: Results from 3 UK clinical trials

    Blood Advances, Vol. 3, Núm. 16, pp. 2474-2481

2018

  1. Proteomics profiling of CLL versus healthy B-cells identifies putative therapeutic targets and a subtype-independent signature of spliceosome dysregulation

    Molecular and Cellular Proteomics, Vol. 17, Núm. 4, pp. 776-791

2017

  1. Maternal BMI at the start of pregnancy and offspring epigenome-wide DNA methylation: Findings from the pregnancy and childhood epigenetics (PACE) consortium

    Human Molecular Genetics, Vol. 26, Núm. 20, pp. 4067-4085

  2. The dual Syk/JAK inhibitor cerdulatinib antagonizes b-cell receptor and microenvironmental signaling in chronic lymphocytic leukemia

    Clinical Cancer Research, Vol. 23, Núm. 9, pp. 2313-2324

2016

  1. Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia

    Leukemia, Vol. 30, Núm. 11, pp. 2179-2186

  2. Longitudinal copy number, whole exome and targeted deep sequencing of 'good risk' IGHV-mutated CLL patients with progressive disease

    Leukemia, Vol. 30, Núm. 6, pp. 1301-1310

  3. Surface IgM expression and function are associated with clinical behavior, genetic abnormalities, and DNA methylation in CLL

    Blood, Vol. 128, Núm. 6, pp. 816-826

  4. The SF3B1 inhibitor spliceostatin A (SSA) elicits apoptosis in chronic lymphocytic leukaemia cells through downregulation of Mcl-1

    Leukemia, Vol. 30, Núm. 2, pp. 351-360

2015

  1. The PI3K/mTOR inhibitor PF-04691502 induces apoptosis and inhibits microenvironmental signaling in CLL and the Eμ-TCL1 mouse model

    Blood, Vol. 125, Núm. 26, pp. 4032-4041

2013

  1. Aberrant DNA methylation profile of chronic and transformed classic Philadelphia-negative myeloproliferative neoplasms

    Haematologica, Vol. 98, Núm. 9, pp. 1414-1420

2011

  1. Defining the critical hurdles in cancer immunotherapy

    Journal of Translational Medicine

  2. Systemic inflammation induces axon injury during brain inflammation

    Annals of Neurology, Vol. 70, Núm. 6, pp. 932-942

2006

  1. JAK2 V617F mutation in classic chronic myeloproliferative diseases: A report on a series of 349 patients [10]

    Leukemia

2004

  1. Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: Two further cases

    Hematology Journal, Vol. 5, Núm. 6, pp. 534-537

  2. NIN, a Gene Encoding a CEP110-Like Centrosomal Protein, Is Fused to PDGFRB in a Patient with a t(5;14)(q33;q24) and an Imatinib-Responsive Myeloproliferative Disorder

    Cancer Research, Vol. 64, Núm. 8, pp. 2673-2676